Table 3 Facilitators to implementing the results of the Magpie Trial by country*
Facilitator | Number of countries from which at least one representative gave a response | |||
|---|---|---|---|---|
| Â | Low and lower-middle income countries (n = 13#) | Upper-middle income countries (n = 3#) | High-income countries (n = 8#) | Total |
Channels to public authorities | 6 | 2 | 2 | 10 |
Development/use of clinical practice guidelines | 4 | 1 | 4 | 9 |
Publications in medical journals | 5 | 0 | 2 | 7 |
Resources | 4 | 1 | 1 | 6 |
International organisations | 4 | 1 | 0 | 5 |
Professional organisations | 2 | 3 | 3 | 8 |
Licensing and availability of magnesium sulphate | 3 | 0 | 3 | 6 |